Close
Help
Need Help?



Proteomic Analysis of Circulating Monocytes Identifies Cathepsin D as A Potential Novel Plasma Marker of Acute Coronary Syndromes

Submit a Paper


Libertas Analytics


1222 Article Views

Publication Date: 14 May 2008

Journal: Clinical Medicine Insights: Cardiology Clinical Medicine: Cardiology 2008:2 191-200

CMIcar
journal

82,573 Article Views

2,778,687 Libertas Article Views

More Statistics

Abstract Maria G. Barderas2, Verónica M. Dardé1,2, Fernando de la Cuesta1, Jose Luis Martin-Ventura3, Luis Miguel Blanco-Colio3, Julio Jiménez-Narcher3, Gloria Alvarez-Llamas1, Lorenzo Lopez-Bescos4, José Tuñón5, Jesús Egido3 and Fernando Vivanco1, 7

1Department of Immunology, 3Vascular Research Laboratory and 5Department of Cardiology, Fundación Jiménez Díaz, Autónoma University, Madrid; 2Vascular Pathophysiology, Hospital Nacional de Paraplejicos, SESCAM, Toledo. 4Fundación Hospital de Alcorcón. 6Hospital de Fuenlabrada. 7Proteomic Unit, Universidad Complutense, Madrid, Spain.

Abstract

We have performed a proteomic analysis of peripheral blood monocytes from ACS patients in comparison with healthy subjects and stable coronary patients in order to search novel biomarkers of ACS in circulating monocytes. Monocytes were isolated from blood of patients with non-ST elevation ACS (n =  27) at day 0, 2 and 6 months, and from patients with stable coronary disease (n =  10) and matched healthy controls (n =  11). The proteomic analysis of monocytes from ACS patients at day 0 showed that cathepsin D is differentially expressed compared to healthy subjects and stable coronary patients. Western blot analysis indicated that the mature form of cathepsin D at day 0 was overexpressed in monocytes of ACS patients in relation to healthy subjects. In contrast, the precursor of this enzyme, absent at day 0 in ACS patients, was highly expressed in monocytes of healthy subjects. Furthermore, the upregulation of the mature form of cathepsin D diminished along the time, while the expression of the precursor increased. ACS patients also showed significantly increased plasma cathepsin D levels on admission compared to healthy subjects and stable patients. Cathepsin D plasma levels diminished at 2 and 6 months to control values. Finally, cathepsin D levels were independent of the existence of coronary risk factors and CRP levels, correlating only with CD40L. Since this protease participates in the genesis and rupture of atherosclerotic plaques, it could represent a potential marker of ACS.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Processing (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES
Our Testimonials
I had an excellent experience publishing our review article in Clinical Medicine Reviews.  The managing editor was very helpful and the process was very timely and transparent.
Professor Jonathan A. Bernstein (University of Cincinnati College of Medicine, Division of Immunology, Allergy Section, Cincinnati, OH, USA) What our authors say